Haoxi Health Technology Ltd. held an extraordinary general meeting of shareholders on December 8, 2025. Shareholders approved a proposal to increase the voting rights attached to each Class B ordinary share from ten votes to thirty votes per share. Another proposal allowing the consolidation of all issued and unissued Class A and Class B ordinary shares at a ratio ranging from two-for-one to one-hundred-and-fifty-for-one, with the exact ratio and date to be determined by the Board, was also approved. Additionally, shareholders approved the adoption of the sixth amended and restated memorandum and articles of association to reflect the changes to voting power and share consolidation.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Haoxi Health Technology Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-120070), on December 10, 2025, and is solely responsible for the information contained therein.
Comments